The Gap
Why Canada Is the Exception
The Patchwork System
Canadians access prescription drugs through a patchwork: employer-provided plans (covering ~60% of the population), provincial programs (varying eligibility — seniors, social assistance recipients, high-cost drug users), and out-of-pocket payment. This creates a three-tier system where access depends on employment status, province of residence, and income. There is no federal floor guaranteeing prescription access for all Canadians.
Bill C-64 — Diabetes and Contraception Only
Bill C-64 (Pharmacare Act) received Royal Assent in October 2024. It establishes a framework for national pharmacare but initially covers only two categories: diabetes medications (including insulin) and contraception. The PBO estimated the first-phase cost at $1.9B per year. Full universal coverage — including cardiovascular drugs, mental health medications, and antibiotics — has no implementation date. The legislation creates the framework without the funding or timeline for universal coverage.
The Hoskins Report (2019) — Ignored for 5 Years
The Advisory Council on the Implementation of National Pharmacare (led by Dr. Eric Hoskins) delivered its final report in June 2019 recommending a universal, single-payer pharmacare system. The report projected savings of $5B annually through bulk purchasing. The government accepted the report and then took five years to pass limited legislation covering only two drug categories. The full Hoskins vision remains unimplemented.
The Implementation Pattern
Promise the programme (2019 campaign). Commission a report (Hoskins). Accept the report. Wait five years. Pass limited legislation (Bill C-64 — two drug categories only). Announce it as historic. Defer full implementation indefinitely. The same pattern as the Canada Disability Benefit: announced as transformational, implemented at $200/month — below the poverty line. The same pattern as every institutional reform documented on this site: legislate the promise, delay the delivery.